Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

Walsh, Dominic M., Klyubin, Igor, Fadeeva, Julia V., Cullen, William K., Anwyl, Roger, Wolfe, Michael S., Rowan, Michael J., Selkoe, Dennis J.·2002·Nature
DOI 10.1038/416535a

Cited by (1,067)

Items 101–200 of 1,067

  1. The Aging Brain
    Yankner, Bruce A., Lu, Tao, Loerch, Patrick · 2008 · Annual Review of Pathology: Mechanisms of Disease
  2. Bioinorganic Chemistry of Alzheimer’s Disease
    Kasper P. Kepp · 2012 · Chemical Reviews
  3. Soluble Aβ Oligomers Inhibit Long-Term Potentiation through a Mechanism Involving Excessive Activation of Extrasynaptic NR2B-Containing NMDA Receptors
    Shaomin Li, Ming Jin, Thomas Koeglsperger, Nina E. Shepardson, Ganesh M. Shankar, Dennis J. Selkoe · 2011 · Journal of Neuroscience
  4. Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases
    Guo, Jing L, Lee, Virginia M Y · 2014 · Nature Medicine
  5. Alzheimer’s disease and the basal forebrain cholinergic system: relations to β-amyloid peptides, cognition, and treatment strategies
    Daniel S. Auld, Tom J. Kornecook, Stéphane Bastianetto, Rémi Quirion · 2002 · Progress in Neurobiology
  6. Widespread protein aggregation as an inherent part of aging in C. elegans
    David, Della C., Ollikainen, Noah, Trinidad, Jonathan C., Cary, Michael P., Burlingame, Alma L., Kenyon, Cynthia · 2010 · PLoS Biology
  7. Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons
    Ji Won Um, Haakon B. Nygaard, Jacqueline K. Heiss, Mikhail A. Kostylev, Massimiliano Stagi, Alexander O. Vortmeyer, Thomas Wısnıewskı, Erik C. Gunther, Stephen M. Strittmatter · 2012 · Nature Neuroscience
  8. Inhibitors of Class 1 Histone Deacetylases Reverse Contextual Memory Deficits in a Mouse Model of Alzheimer's Disease
    Kilgore, Mark, Miller, Courtney A, Fass, Daniel M, Hennig, Krista M, Haggarty, Stephen J, Sweatt, J David, Rumbaugh, Gavin · 2010 · Neuropsychopharmacology
  9. Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomers
    De Felice, Fernanda G., Vieira, Marcelo N. N., Bomfim, Theresa R., Decker, Helena, Velasco, Pauline T., Lambert, Mary P., Viola, Kirsten L., Zhao, Wei-Qin, Ferreira, Sergio T., Klein, William L. · 2009 · Proceedings of the National Academy of Sciences
  10. Amyloid-β/Fyn–Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease
    Roberson, Erik D., Halabisky, Brian, Yoo, Jong W., Yao, Jinghua, Chin, Jeannie, Yan, Fengrong, Wu, Tiffany, Hamto, Patricia, Devidze, Nino, Yu, Gui-Qiu et al. · 2011 · The Journal of Neuroscience
  11. Detection of oligomeric forms of α‐synuclein protein in human plasma as a potential biomarker for Parkinson's disease
    El‐Agnaf, Omar M. A., Salem, Sultan A., Paleologou, Katerina E., Curran, Martin D., Gibson, Mark J., Court, Jennifer A., Schlossmacher, Michael G., Allsop, David · 2006 · The FASEB Journal
  12. A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model
    Postina, Rolf, Schroeder, Anja, Dewachter, Ilse, Bohl, Juergen, Schmitt, Ulrich, Kojro, Elzbieta, Prinzen, Claudia, Endres, Kristina, Hiemke, Christoph, Blessing, Manfred et al. · 2004 · Journal of Clinical Investigation
  13. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs
    Agrawal, Mukta, Saraf, Swarnlata, Saraf, Shailendra, Antimisiaris, Sophia G., Chougule, Mahavir Bhupal, Shoyele, Sunday A., Alexander, Amit · 2018 · Journal of Controlled Release
  14. Amyloid β oligomers in Alzheimer’s disease pathogenesis, treatment, and diagnosis
    Viola, Kirsten L., Klein, William L. · 2015 · Acta Neuropathologica
  15. Alzheimer's Disease: From Pathology to Therapeutic Approaches
    Jakob‐Roetne, Roland, Jacobsen, Helmut · 2009 · Angewandte Chemie International Edition
  16. Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report
    Arboleda-Velasquez, Joseph F., Lopera, Francisco, O’Hare, Michael, Delgado-Tirado, Santiago, Marino, Claudia, Chmielewska, Natalia, Saez-Torres, Kahira L., Amarnani, Dhanesh, Schultz, Aaron P., Sperling, Reisa A. et al. · 2019 · Nature Medicine
  17. A multimodal RAGE-specific inhibitor reduces amyloid β–mediated brain disorder in a mouse model of Alzheimer disease
    Deane, Rashid, Singh, Itender, Sagare, Abhay P., Bell, Robert D., Ross, Nathan T., LaRue, Barbra, Love, Rachal, Perry, Sheldon, Paquette, Nicole, Deane, Richard J. et al. · 2012 · Journal of Clinical Investigation
  18. Effects of secreted oligomers of amyloid β‐protein on hippocampal synaptic plasticity: a potent role for trimers
    Townsend, Matthew, Shankar, Ganesh M., Mehta, Tapan, Walsh, Dominic M., Selkoe, Dennis J. · 2006 · The Journal of Physiology
  19. The redox chemistry of the Alzheimer's disease amyloid β peptide
    Smith, Danielle G., Cappai, Roberto, Barnham, Kevin J. · 2007 · Biochimica et Biophysica Acta (BBA) - Biomembranes
  20. What is the role of protein aggregation in neurodegeneration?
    Christopher A. Ross, Michelle A. Poirier · 2005 · Nature Reviews Molecular Cell Biology
  21. Astrocyte Senescence as a Component of Alzheimer’s Disease
    Bhat, Rekha, Crowe, Elizabeth P., Bitto, Alessandro, Moh, Michelle, Katsetos, Christos D., Garcia, Fernando U., Johnson, Frederick Bradley, Trojanowski, John Q., Sell, Christian, Torres, Claudio · 2012 · PLoS ONE
  22. Amyloid oligomers: formation and toxicity of Aβ oligomers
    Masafumi Sakono, Tamotsu Zako · 2010 · FEBS Journal
  23. Suppression of glymphatic fluid transport in a mouse model of Alzheimer's disease
    Peng, Weiguo, Achariyar, Thiyagarajan M., Li, Baoman, Liao, Yonghong, Mestre, Humberto, Hitomi, Emi, Regan, Sean, Kasper, Tristan, Peng, Sisi, Ding, Fengfei et al. · 2016 · Neurobiology of Disease
  24. Amyloidogenic Protein–Membrane Interactions: Mechanistic Insight from Model Systems
    Sara M. Butterfield, Hilal Ahmed Lashuel · 2010 · Angewandte Chemie International Edition
  25. Functional Alterations in Memory Networks in Early Alzheimer’s Disease
    Reisa Anne Sperling, Bradford Clark Dickerson, Maija M. Pihlajamaki, Patrizia Vannini, Peter S. LaViolette, Ottavio V. Vitolo, Trey Hedden, John Alex Becker, Dorene M. Rentz, Dennis J. Selkoe et al. · 2010 · NeuroMolecular Medicine
  26. The road to restoring neural circuits for the treatment of Alzheimer's disease
    Canter, Rebecca G., Penney, Jay, Tsai, Li-Huei · 2016 · Nature
  27. Amyloid Fibrils as Building Blocks for Natural and Artificial Functional Materials
    Tuomas P. J. Knowles, Raffaele Mezzenga · 2016 · Advanced Materials
  28. The Cell Biology of Synaptic Plasticity
    Ho, Victoria M., Lee, Ji-Ann, Martin, Kelsey C. · 2011 · Science
  29. Amyloid beta oligomers induce impairment of neuronal insulin receptors
    Zhao, Wei‐Qin, De Felice, Fernanda G., Fernandez, Sara, Chen, Hui, Lambert, Mary P., Quon, Michael J., Krafft, Grant A., Klein, William L. · 2008 · The FASEB Journal
  30. Traumatic brain injury and amyloid-β pathology: a link to Alzheimer's disease?
    Johnson, Victoria E., Stewart, William, Smith, Douglas H. · 2010 · Nature Reviews Neuroscience
  31. Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: The emerging role of oligomeric assemblies
    Marina D. Kirkitadze, Gal Bitan, David B. Teplow · 2002 · Journal of Neuroscience Research
  32. Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease
    Shichun Tu, Shu‐ichi Okamoto, Stuart A. Lipton, Huaxi Xu · 2014 · Molecular Neurodegeneration
  33. Inflammatory processes in Alzheimer's disease
    Heneka, Michael T., O'Banion, M. Kerry · 2007 · Journal of Neuroimmunology
  34. Common mechanisms of amyloid oligomer pathogenesis in degenerative disease
    Glabe, Charles G. · 2006 · Neurobiology of Aging
  35. The Formation of Highly Soluble Oligomers of α-Synuclein Is Regulated by Fatty Acids and Enhanced in Parkinson's Disease
    Ronit Sharon, Ifat Bar-Joseph, Matthew P. Frosch, Dominic M. Walsh, James A. Hamilton, Dennis J. Selkoe · 2003 · Neuron
  36. Dendritic Spine Abnormalities in Amyloid Precursor Protein Transgenic Mice Demonstrated by Gene Transfer and Intravital Multiphoton Microscopy
    Spires, Tara L., Meyer-Luehmann, Melanie, Stern, Edward A., McLean, Pamela J., Skoch, Jesse, Nguyen, Paul T., Bacskai, Brian J., Hyman, Bradley T. · 2005 · The Journal of Neuroscience
  37. Globular amyloid β‐peptide <sub>1−42</sub> oligomer − a homogenous and stable neuropathological protein in Alzheimer's disease
    Barghorn, Stefan, Nimmrich, Volker, Striebinger, Andreas, Krantz, Carsten, Keller, Patrick, Janson, Bodo, Bahr, Michael, Schmidt, Martin, Bitner, Robert S., Harlan, John et al. · 2005 · Journal of Neurochemistry
  38. Protein Aggregation in the Brain: The Molecular Basis for Alzheimer’s and Parkinson’s Diseases
    G. Brent Irvine, Omar M. A. El‐Agnaf, Ganesh M. Shankar, Dominic M. Walsh · 2008 · Molecular Medicine
  39. Evidence of fibril-like β-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's β-amyloid
    Sandra Chimon, Medhat A. Shaibat, Christopher R Jones, Diana C Calero, Buzulagu Aizezi, Yoshitaka Ishii · 2007 · Nature Structural & Molecular Biology
  40. Synaptic degeneration in Alzheimer's disease
    Arendt, Thomas · 2009 · Acta Neuropathologica
  41. Insulin, insulin-degrading enzyme and amyloid-β peptide in Alzheimer's disease: review and hypothesis
    Wei Qiao Qiu, Marshal F. Folstein · 2005 · Neurobiology of Aging
  42. Amyloid-Beta: A Crucial Factor in Alzheimer's Disease
    Saeed Sadigh‐Eteghad, Babak Sabermarouf, Alireza Majdi, Mahnaz Talebi, Mehdi Farhoudi, Javad Mahmoudi · 2014 · Medical Principles and Practice
  43. Amyloid β-peptide inhibition of the PKA/CREB pathway and long-term potentiation: Reversibility by drugs that enhance cAMP signaling
    Vitolo, Ottavio V., Sant'Angelo, Antonino, Costanzo, Vincenzo, Battaglia, Fortunato, Arancio, Ottavio, Shelanski, Michael · 2002 · Proceedings of the National Academy of Sciences
  44. A Transgenic Alzheimer Rat with Plaques, Tau Pathology, Behavioral Impairment, Oligomeric Aβ, and Frank Neuronal Loss
    Robert M. Cohen, Kavon P. Rezai-Zadeh, Tara M. Weitz, Altan Rentsendorj, David Gate, Inna E Spivak, Yasmin Bholat, Vitaly Vasilevko, Charles G. Glabe, Joshua J. Breunig et al. · 2013 · Journal of Neuroscience
  45. Reelin, lipoprotein receptors and synaptic plasticity
    Herz, Joachim, Chen, Ying · 2006 · Nature Reviews Neuroscience
  46. Neurotoxicity of Alzheimer’s disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio
    Kuperstein, Inna, Broersen, Kerensa, Benilova, Iryna, Rozenski, Jef, Jonckheere, Wim, Debulpaep, Maja, Vandersteen, Annelies, Segers‐Nolten, Ine, Van Der Werf, Kees, Subramaniam, Vinod et al. · 2010 · The EMBO Journal
  47. The Role of NMDA Receptors in Alzheimer’s Disease
    Liu, Jinping, Chang, Lirong, Song, Yizhi, Li, Hui, Wu, Yan · 2019 · Frontiers in Neuroscience
  48. The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease
    Reinhard Schliebs, Thomas Arendt · 2006 · Journal of Neural Transmission
  49. Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
    Sardar Sinha, Maitrayee, Ansell-Schultz, Anna, Civitelli, Livia, Hildesjö, Camilla, Larsson, Max, Lannfelt, Lars, Ingelsson, Martin, Hallbeck, Martin · 2018 · Acta Neuropathologica
  50. Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease
    Takahiko Tokuda, M.M. Qureshi, Mustafa Taleb Ardah, S. Varghese, Safa A. S. Shehab, Takashi Kasai, Noriko Ishigami, Akira Tamaoka, M. Nakagawa, Omar M. A. El‐Agnaf · 2010 · Neurology
  51. Prevention of Transthyretin Amyloid Disease by Changing Protein Misfolding Energetics
    Per Hammarström, R. Luke Wiseman, Evan T. Powers, Jeffery W. Kelly · 2003 · Science
  52. Solution NMR Studies of the Aβ(1−40) and Aβ(1−42) Peptides Establish that the Met35 Oxidation State Affects the Mechanism of Amyloid Formation
    Liming Hou, Haiyan Shao, Yongbo Zhang, Hua Long Li, N K Menon, Elizabeth B. Neuhaus, John M. Brewer, In‐Ja L. Byeon, Dale G. Ray, Michael Peter Vitek et al. · 2004 · Journal of the American Chemical Society
  53. Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease
    Lovell, M. A., Markesbery, W. R. · 2007 · Nucleic Acids Research
  54. Alzheimer's disease: synaptic dysfunction and Aβ
    Ganesh M. Shankar, Dominic M. Walsh · 2009 · Molecular Neurodegeneration
  55. Localized Surface Plasmon Resonance Biosensors
    Jing Zhao, Xiaoyu Zhang, Chanda Ranjit Yonzon, Amanda J. Haes, Richard P. Van Duyne · 2006 · Nanomedicine
  56. Synaptic degeneration in Alzheimer disease
    Tzioras, Makis, McGeachan, Robert I., Durrant, Claire S., Spires-Jones, Tara L. · 2023 · Nature Reviews Neurology
  57. Alzheimer's disease, β‐amyloid, glutamate, NMDA receptors and memantine – searching for the connections
    Danysz, Wojciech, Parsons, Chris G · 2012 · British Journal of Pharmacology
  58. Spherical aggregates of β-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3β
    Minako M. Hoshi, Michio Sato, Shinichiro Matsumoto, Akihiko Noguchi, Kaori Yasutake, Natsuko Yoshida, Kazuki Sato · 2003 · Proceedings of the National Academy of Sciences
  59. Antiparallel β-sheet: a signature structure of the oligomeric amyloid β-peptide
    Emilie Cerf, Rabia Sarroukh, Shiori Tamamizu‐Kato, Leonid Breydo, Sylvie Derclaye, Yves F. Dufrêne, Vasanthy Narayanaswami, Erik Goormaghtigh, Jean‐Marie Ruysschaert, Vincent Raussens · 2009 · Biochemical Journal
  60. Different Conformations of Amyloid β Induce Neurotoxicity by Distinct Mechanisms in Human Cortical Neurons
    Atul M. Deshpande, Erene W. Mina, Charles G. Glabe, Jorge A. Busciglio · 2006 · Journal of Neuroscience
  61. Amyloid β protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivo
    Klyubin, Igor, Walsh, Dominic M, Lemere, Cynthia A, Cullen, William K, Shankar, Ganesh M, Betts, Vicki, Spooner, Edward T, Jiang, Liying, Anwyl, Roger, Selkoe, Dennis J et al. · 2005 · Nature Medicine
  62. Accumulation of Pathological Tau Species and Memory Loss in a Conditional Model of Tauopathy
    Zdenek Berger, Hanno M. Roder, Amanda Hanna, Aaron M. Carlson, Vijayaraghavan Rangachari, Mei Yue, Zbigniew K. Wszołek, Karen H. Ashe, Joshua A. Knight, Dennis W. Dickson et al. · 2007 · Journal of Neuroscience
  63. Modulation of the endoplasmic reticulum–mitochondria interface in Alzheimer’s disease and related models
    Hedskog, Louise, Pinho, Catarina Moreira, Filadi, Riccardo, Rönnbäck, Annica, Hertwig, Laura, Wiehager, Birgitta, Larssen, Pia, Gellhaar, Sandra, Sandebring, Anna, Westerlund, Marie et al. · 2013 · Proceedings of the National Academy of Sciences
  64. Small assemblies of unmodified amyloid $beta;-protein are the proximate neurotoxin in Alzheimer?s disease
    William L. Klein, W. Blaine Stine, David B. Teplow · 2004 · Neurobiology of Aging
  65. Dissecting the pathological effects of human Aβ40 and Aβ42 in Drosophila : A potential model for Alzheimer's disease
    Koichi Iijima, Hsin‐Ping Liu, Ann‐Shyn Chiang, Stephen Hearn, Mary Konsolaki, Yi Zhong · 2004 · Proceedings of the National Academy of Sciences
  66. From Macroscopic Measurements to Microscopic Mechanisms of Protein Aggregation
    Samuel I. A. Cohen, Michele Vendruscolo, Christopher Martin Dobson, Tuomas P. J. Knowles · 2012 · Journal of Molecular Biology
  67. A Hundred Years of Alzheimer's Disease Research
    Hardy, John · 2006 · Neuron
  68. Secondary nucleation in amyloid formation
    Mattias Törnquist, Thomas C. T. Michaels, Kalyani Sanagavarapu, Xiaoting Yang, Georg Meisl, Samuel I. A. Cohen, Tuomas P. J. Knowles, Sara Snogerup Linse · 2018 · Chemical Communications
  69. Deleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5
    Renner, Marianne, Lacor, Pascale N., Velasco, Pauline T., Xu, Jian, Contractor, Anis, Klein, William L., Triller, Antoine · 2010 · Neuron
  70. Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease.
    Sarah Mueller-Steiner, Yun-Gui Zhou, H. Arai, E. Roberson, Bing-Gui Sun, Jennifer Chen, Xin Wang, Gui-Qiu Yu, Luke Esposito, L. Mucke et al. · 2006 · Neuron
  71. BACE1 Deficiency Rescues Memory Deficits and Cholinergic Dysfunction in a Mouse Model of Alzheimer's Disease
    Ohno, Masuo, Sametsky, Evgeny A, Younkin, Linda H, Oakley, Holly, Younkin, Steven G, Citron, Martin, Vassar, Robert, Disterhoft, John F · 2004 · Neuron
  72. BACE1, a Major Determinant of Selective Vulnerability of the Brain to Amyloid-β Amyloidogenesis, is Essential for Cognitive, Emotional, and Synaptic Functions
    Laird, Fiona M., Cai, Huaibin, Savonenko, Alena V., Farah, Mohamed H., He, Kaiwen, Melnikova, Tatyana, Wen, Hongjin, Chiang, Hsueh-Cheng, Xu, Guilian, Koliatsos, Vassilis E. et al. · 2005 · The Journal of Neuroscience
  73. Synapses and Alzheimer's Disease
    Sheng, M., Sabatini, B. L., Sudhof, T. C. · 2012 · Cold Spring Harbor Perspectives in Biology
  74. The physiological roles of tau and Aβ: implications for Alzheimer’s disease pathology and therapeutics
    Kent, Sarah A., Spires-Jones, Tara L., Durrant, Claire S. · 2020 · Acta Neuropathologica
  75. Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimers Disease
    Suzanne M. de la Monte · 2012 · Current Alzheimer Research
  76. Role of toll-like receptor signalling in A uptake and clearance
    Tahara, K., Kim, H.-D., Jin, J.-J., Maxwell, J. A., Li, L., Fukuchi, K.-i. · 2006 · Brain
  77. Amyloid toxicity in Alzheimer’s disease
    Reiss, Allison B., Arain, Hirra A., Stecker, Mark M., Siegart, Nicolle M., Kasselman, Lora J. · 2018 · Reviews in the Neurosciences
  78. Small-molecule conversion of toxic oligomers to nontoxic β-sheet–rich amyloid fibrils
    Jan Bieschke, Martin Herbst, Thomas Wiglenda, Ralf P. Friedrich, Annett Boeddrich, Franziska Schiele, Daniela Kleckers, Juan Miguel López del Amo, Björn Andreas Grüning, Qinwen Wang et al. · 2011 · Nature Chemical Biology
  79. Amyloid Polymorphism: Structural Basis and Neurobiological Relevance
    Robert Tycko · 2015 · Neuron
  80. Recent advances in the multitarget‐directed ligands approach for the treatment of Alzheimer's disease
    Rafael M. Leon, Antonio G. Garcı́a, Jose Luis Marco · 2011 · Medicinal Research Reviews
  81. Alzheimer disease models and human neuropathology: similarities and differences
    Charles J. Duyckaerts, Marie‐Claude Potier, Benoı̂t Delatour · 2007 · Acta Neuropathologica
  82. The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease
    Ferreira, Sergio T., Klein, William L. · 2011 · Neurobiology of Learning and Memory
  83. The α‐to‐β Conformational Transition of Alzheimer's Aβ‐(1–42) Peptide in Aqueous Media is Reversible: A Step by Step Conformational Analysis Suggests the Location of β Conformation Seeding
    Simona Tomaselli, Veronica Esposito, Paolo Vangone, Nico A. J. van Nuland, Alexandre M. J. J. Bonvin, Remo Guerrini, Teodorico Tancredi, Piero Andrea Temussi, Delia Picone · 2006 · ChemBioChem
  84. Block of Long-Term Potentiation by Naturally Secreted and Synthetic Amyloid β-Peptide in Hippocampal Slices Is Mediated via Activation of the Kinases c-Jun N-Terminal Kinase, Cyclin-Dependent Kinase 5, and p38 Mitogen-Activated Protein Kinase as well as Metabotropic Glutamate Receptor Type 5
    Wang, Qinwen, Walsh, Dominic M., Rowan, Michael J., Selkoe, Dennis J., Anwyl, Roger · 2004 · The Journal of Neuroscience
  85. Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment
    Gong, Bing, Vitolo, Ottavio V., Trinchese, Fabrizio, Liu, Shumin, Shelanski, Michael, Arancio, Ottavio · 2004 · Journal of Clinical Investigation
  86. Neuroinflammatory processes in Alzheimer’s disease
    Heneka, Michael T., O’Banion, M. Kerry, Terwel, Dick, Kummer, Markus Peter · 2010 · Journal of Neural Transmission
  87. Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers
    De Felice, Fernanda G., Wu, Diana, Lambert, Mary P., Fernandez, Sara J., Velasco, Pauline T., Lacor, Pascale N., Bigio, Eileen H., Jerecic, Jasna, Acton, Paul J., Shughrue, Paul J. et al. · 2008 · Neurobiology of Aging
  88. Reversing EphB2 depletion rescues cognitive functions in Alzheimer model
    Cissé, Moustapha, Halabisky, Brian, Harris, Julie, Devidze, Nino, Dubal, Dena B., Sun, Binggui, Orr, Anna, Lotz, Gregor, Kim, Daniel H., Hamto, Patricia et al. · 2011 · Nature
  89. Alzheimer's disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis.
    G. Silverberg, M. Mayo, Thomas Saul, E. Rubenstein, D. Mcguire · 2003 · Lancet Neurology
  90. Strategies for disease modification in Alzheimer's disease
    Martin Citron · 2004 · Nature reviews. Neuroscience
  91. Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model
    Oded Singer, Robert A. Marr, Edward M. Rockenstein, Leslie A. Crews, Nicole G. Coufal, Fred H. Gage, Inder M. Verma, Eliezer Masliah · 2005 · Nature Neuroscience
  92. Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide
    Hu, Xiaoyan, Crick, Scott L., Bu, Guojun, Frieden, Carl, Pappu, Rohit V., Lee, Jin-Moo · 2009 · Proceedings of the National Academy of Sciences
  93. Redox‐Active Metals, Oxidative Stress, and Alzheimer's Disease Pathology
    HUANG, XUDONG, MOIR, ROBERT D., TANZI, RUDOLPH E., BUSH, ASHLEY I., ROGERS, JACK T. · 2004 · Annals of the New York Academy of Sciences
  94. Ubiquitin Hydrolase Uch-L1 Rescues β-Amyloid-Induced Decreases in Synaptic Function and Contextual Memory
    Bing Gong, Zixuan Cao, Ping Zheng, Ottavio V. Vitolo, Shumin Liu, Agnieszka Staniszewski, Donna L. Moolman, Hong Zhang, Michael L. Shelanski, Ottavio Arancio · 2006 · Cell
  95. Protein aggregation in crowded environments
    R. John Ellis, Allen P. Minton · 2006 · Biological Chemistry
  96. β-Amyloid Monomers Are Neuroprotective
    Giuffrida, Maria Laura, Caraci, Filippo, Pignataro, Bruno, Cataldo, Sebastiano, De Bona, Paolo, Bruno, Valeria, Molinaro, Gemma, Pappalardo, Giuseppe, Messina, Angela, Palmigiano, Angelo et al. · 2009 · The Journal of Neuroscience
  97. A new amyloid β variant favoring oligomerization in Alzheimer's‐type dementia
    Takami Tomiyama, Tetsu Nagata, Hiroyuki Shimada, Rie Teraoka, Akiko Fukushima, Hyoue Kanemitsu, Hiroshi Takuma, Ryozo Kuwano, Masaki Imagawa, Suzuka Ataka et al. · 2008 · Annals of Neurology
  98. Memory Impairment in Transgenic Alzheimer Mice Requires Cellular Prion Protein
    Gimbel, David A., Nygaard, Haakon B., Coffey, Erin E., Gunther, Erik C., Laurén, Juha, Gimbel, Zachary A., Strittmatter, Stephen M. · 2010 · The Journal of Neuroscience
  99. Brain Energy and Oxygen Metabolism: Emerging Role in Normal Function and Disease
    Michelle Evelyn Watts, Roger Pocock, Charles Claudianos · 2018 · Frontiers in Molecular Neuroscience
  100. A Recessive Mutation in the APP Gene with Dominant-Negative Effect on Amyloidogenesis
    Giuseppe Di Fede, Marcella Catania, Michela Morbin, Giacomina Rossi, Silvia Suardi, Giulia Mazzoleni, Marco Merlin, Anna Rıta Gıovagnolı, Sara Prioni, Alessandra Erbetta et al. · 2009 · Science